RBMXL3
gene geneOn this page
Also known as FLJ40249
Summary
RBMXL3 (RBMX like 3, HGNC:26859) is a protein-coding gene on chromosome Xq23, encoding RNA-binding motif protein, X-linked-like-3 (Q8N7X1). RNA-binding protein involved in glucocorticoid regulation of pulmonary surfactant protein B (SFTPB) mRNA stability.
Predicted to enable mRNA binding activity and snRNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome.
Source: NCBI Gene 139804 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001145346
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26859 |
| Approved symbol | RBMXL3 |
| Name | RBMX like 3 |
| Location | Xq23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40249 |
| Ensembl gene | ENSG00000175718 |
| Ensembl biotype | protein_coding |
| OMIM | 301136 |
| Entrez | 139804 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000424776
RefSeq mRNA: 1 — MANE Select: NM_001145346
NM_001145346
CCDS: CCDS55478
Canonical transcript exons
ENST00000424776 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001785091 | 115189410 | 115192868 |
Expression profiles
Bgee: expression breadth tissue_specific, 6 present calls, max score 73.36.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.36 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.58 | gold quality |
| right testis | UBERON:0004534 | 58.31 | gold quality |
| testis | UBERON:0000473 | 56.61 | gold quality |
| left testis | UBERON:0004533 | 56.03 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.25 | gold quality |
| bone marrow cell | CL:0002092 | 38.01 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.04 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| sural nerve | UBERON:0015488 | 35.15 | gold quality |
| tonsil | UBERON:0002372 | 34.31 | gold quality |
| muscle tissue | UBERON:0002385 | 33.01 | gold quality |
| bone marrow | UBERON:0002371 | 32.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| urinary bladder | UBERON:0001255 | 31.00 | gold quality |
| liver | UBERON:0002107 | 30.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 30.41 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 29.88 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.66 | gold quality |
| lymph node | UBERON:0000029 | 28.74 | gold quality |
| monocyte | CL:0000576 | 28.63 | gold quality |
| leukocyte | CL:0000738 | 28.54 | gold quality |
| uterine cervix | UBERON:0000002 | 28.38 | gold quality |
| calcaneal tendon | UBERON:0003701 | 28.33 | gold quality |
| cortex of kidney | UBERON:0001225 | 28.29 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| myometrium | UBERON:0001296 | 28.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting RBMXL3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-3136-3P | 99.57 | 66.59 | 781 |
| HSA-MIR-7155-3P | 99.57 | 66.48 | 794 |
| HSA-MIR-3923 | 99.52 | 69.21 | 446 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-4773 | 98.35 | 67.30 | 1710 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-6773-5P | 97.04 | 64.30 | 595 |
| HSA-MIR-3189-3P | 96.80 | 66.34 | 896 |
| HSA-MIR-6724-5P | 96.41 | 63.11 | 507 |
| HSA-MIR-4683 | 95.29 | 65.98 | 631 |
| HSA-MIR-554 | 95.20 | 66.98 | 341 |
| HSA-MIR-1229-5P | 94.57 | 65.78 | 487 |
Literature-anchored findings (GeneRIF, showing 1)
- A primate-specific RNA-binding protein (RBMXL3) is involved in glucocorticoid regulation of human pulmonary surfactant protein B (SP-B) mRNA stability. (PMID:33719563)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rbmxl2 | ENSMUSG00000073894 |
| rattus_norvegicus | Rbmxl2 | ENSRNOG00000090098 |
Paralogs (36): DAZAP1 (ENSG00000071626), CIRBP (ENSG00000099622), RBM23 (ENSG00000100461), RBM3 (ENSG00000102317), NCL (ENSG00000115053), TIA1 (ENSG00000116001), HNRNPA2B1 (ENSG00000122566), RBM19 (ENSG00000122965), RBM39 (ENSG00000131051), MSI1 (ENSG00000135097), HNRNPA1 (ENSG00000135486), HNRNPD (ENSG00000138668), HNRNPA1L2 (ENSG00000139675), RBMX (ENSG00000147274), A1CF (ENSG00000148584), TIAL1 (ENSG00000151923), RBM46 (ENSG00000151962), HNRNPDL (ENSG00000152795), MSI2 (ENSG00000153944), RBM47 (ENSG00000163694), RBMY1F (ENSG00000169800), HNRNPA3 (ENSG00000170144), RBMXL2 (ENSG00000170748), RBM4B (ENSG00000173914), RBM4 (ENSG00000173933), HNRNPA0 (ENSG00000177733), TRNAU1AP (ENSG00000180098), HNRNPAB (ENSG00000197451), RBMXL1 (ENSG00000213516), HNRNPA1L3 (ENSG00000224578), RBMY1J (ENSG00000226941), RBMY1A1 (ENSG00000234414), RBMY1E (ENSG00000242389), RBMY1B (ENSG00000242875), RBMY1D (ENSG00000244395), DND1 (ENSG00000256453)
Protein
Protein identifiers
RNA-binding motif protein, X-linked-like-3 — Q8N7X1 (reviewed: Q8N7X1)
All UniProt accessions (1): Q8N7X1
UniProt curated annotations — full annotation on UniProt →
Function. RNA-binding protein involved in glucocorticoid regulation of pulmonary surfactant protein B (SFTPB) mRNA stability.
RefSeq proteins (1): NP_001138818* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR050441 | RBM | Family |
Pfam: PF00076
UniProt features (30 total): compositionally biased region 15, sequence conflict 9, region of interest 4, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7X1-F1 | 40.87 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOBP_RNA_SPLICING, GOMF_MRNA_BINDING, GOMF_SNRNA_BINDING, chrXq23, GOBP_MRNA_PROCESSING, MAFG_TARGET_GENES, MIR4422, MIR548BA, MIR548AI_MIR570_5P, MIR548AG, MIR4683, MIR6773_5P, MIR1229_5P, MIR6724_5P, GOBP_MRNA_METABOLIC_PROCESS
GO Biological Process (1): mRNA splicing, via spliceosome (GO:0000398)
GO Molecular Function (4): RNA binding (GO:0003723), mRNA binding (GO:0003729), snRNA binding (GO:0017069), nucleic acid binding (GO:0003676)
GO Cellular Component (1): organelle (GO:0043226)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA binding | 2 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1514 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RBMXL3 | HNRNPC | P07910 | 497 |
| RBMXL3 | KHDRBS1 | Q07666 | 414 |
| RBMXL3 | TEKTL1 | Q8IYK2 | 383 |
| RBMXL3 | LRRIQ4 | A6NIV6 | 362 |
| RBMXL3 | YTHDC2 | Q9H6S0 | 355 |
| RBMXL3 | FRG1 | Q14331 | 355 |
| RBMXL3 | WTAP | Q15007 | 344 |
| RBMXL3 | YTHDC1 | Q96MU7 | 344 |
| RBMXL3 | METTL16 | Q86W50 | 337 |
| RBMXL3 | ALKBH1 | Q13686 | 325 |
| RBMXL3 | ETV3L | Q6ZN32 | 316 |
| RBMXL3 | MAGEB16 | A2A368 | 311 |
| RBMXL3 | ALKBH5 | Q6P6C2 | 309 |
| RBMXL3 | YTHDF1 | Q9BYJ9 | 307 |
| RBMXL3 | METTL14 | Q9HCE5 | 304 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| N | HNRNPDL | psi-mi:“MI:0914”(association) | 0.530 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| KRAS | IGKV2D-29 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): RBMXL3 (Affinity Capture-MS), RBMXL3 (Proximity Label-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Affinity Capture-MS), RBMXL3 (Protein-RNA), RBMXL3 (Affinity Capture-MS)
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1
Diamond homologs: A0A0A0LLY1, A0A0D1C8Z4, A5A6M3, C0HFE5, D3Z4I3, D4AE41, M0R7T6, O22703, O35698, O75526, O89086, O93235, P04147, P0C8Z4, P10979, P19682, P19683, P19684, P28644, P38159, P39697, P48809, P49310, P49311, P49313, P49314, P60824, P60825, P60826, P84586, P98179, Q03250, Q03251, Q03878, Q04836, Q05966, Q08473, Q08935, Q08937, Q14011
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
131 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:115189413:T:TA | donor_gain | 0.9800 |
| X:115190449:G:A | donor_gain | 0.9000 |
| X:115189486:CA:C | donor_gain | 0.8900 |
| X:115189487:AA:A | donor_gain | 0.8900 |
| X:115189485:TCA:T | donor_gain | 0.8300 |
| X:115189654:C:T | donor_gain | 0.8000 |
| X:115190146:AGG:A | donor_gain | 0.7300 |
| X:115190146:AGGC:A | donor_gain | 0.7200 |
| X:115189491:TCAAA:T | donor_gain | 0.7000 |
| X:115190456:G:A | donor_gain | 0.6800 |
| X:115189422:C:T | donor_gain | 0.6200 |
| X:115189584:C:CA | acceptor_gain | 0.6000 |
| X:115190254:C:CT | donor_gain | 0.5700 |
| X:115190255:T:TT | donor_gain | 0.5700 |
| X:115189427:A:T | donor_gain | 0.5600 |
| X:115189423:C:T | donor_gain | 0.5500 |
| X:115189419:G:T | donor_gain | 0.5200 |
| X:115189426:CA:C | donor_gain | 0.5100 |
| X:115190527:G:A | donor_gain | 0.5100 |
| X:115189554:T:TA | donor_gain | 0.5000 |
| X:115192867:T:C | donor_gain | 0.5000 |
| X:115190146:AGGCC:A | donor_gain | 0.4800 |
| X:115189851:TCG:T | donor_gain | 0.4700 |
| X:115189488:A:C | donor_gain | 0.4600 |
| X:115189414:C:A | donor_gain | 0.4500 |
| X:115190200:C:A | donor_gain | 0.4400 |
| X:115190342:C:CT | donor_gain | 0.4400 |
| X:115189957:CAG:C | donor_gain | 0.4200 |
| X:115189656:A:AC | donor_gain | 0.4100 |
| X:115189419:G:GT | donor_gain | 0.3900 |
AlphaMissense
6954 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:115189592:T:C | F51L | 0.998 |
| X:115189594:C:A | F51L | 0.998 |
| X:115189594:C:G | F51L | 0.998 |
| X:115189602:T:A | V54D | 0.998 |
| X:115189607:T:C | F56L | 0.998 |
| X:115189609:C:A | F56L | 0.998 |
| X:115189609:C:G | F56L | 0.998 |
| X:115189608:T:C | F56S | 0.997 |
| X:115189598:T:C | F53L | 0.996 |
| X:115189600:C:A | F53L | 0.996 |
| X:115189600:C:G | F53L | 0.996 |
| X:115189472:T:C | F11L | 0.995 |
| X:115189474:C:A | F11L | 0.995 |
| X:115189474:C:G | F11L | 0.995 |
| X:115189523:T:C | F28L | 0.995 |
| X:115189525:T:A | F28L | 0.995 |
| X:115189525:T:G | F28L | 0.995 |
| X:115189593:T:C | F51S | 0.995 |
| X:115189473:T:C | F11S | 0.994 |
| X:115189524:T:C | F28S | 0.994 |
| X:115189635:C:A | A65D | 0.993 |
| X:115189512:T:A | L24H | 0.992 |
| X:115189596:C:A | A52E | 0.992 |
| X:115189599:T:C | F53S | 0.991 |
| X:115189608:T:G | F56C | 0.991 |
| X:115189470:T:C | L10P | 0.990 |
| X:115189476:T:A | I12N | 0.989 |
| X:115189512:T:C | L24P | 0.989 |
| X:115189485:T:C | L15P | 0.988 |
| X:115189634:G:C | A65P | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000843178 (X:115189944 C>G,T), RS1002469427 (X:115190100 G>A), RS1002926891 (X:115191727 G>A,C,T), RS1005511741 (X:115191115 C>T), RS1005667785 (X:115193157 A>T), RS1005694529 (X:115189194 G>C), RS1005719965 (X:115192689 A>G), RS1007143175 (X:115189909 C>A,G), RS1007583913 (X:115189826 G>C), RS1009145759 (X:115190598 A>C,G), RS1010569231 (X:115192256 C>A,T), RS1010621570 (X:115192094 C>T), RS1011884863 (X:115189403 A>G,T), RS1012325921 (X:115189148 T>A), RS1013300424 (X:115187444 C>A)
Disease associations
OMIM: gene MIM:301136 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| FR900359 | increases phosphorylation | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.